SOURCE: Xact Aid

October 25, 2005 14:00 ET

Xact Aid, Inc. Retains Services of Dr. David Stark

WESTLAKE VILLAGE, CA -- (MARKET WIRE) -- October 25, 2005 -- Xact Aid, Inc. (OTC BB: XAID) is pleased to announce that it has retained the services of Dr. David Stark to manage and draft the test protocols and implement the FDA trials of Xact Aid, Inc.'s diagnostic testing products and devises.

Dr. Stark has broad experiences in the inner workings of research and regulatory aspects of FDA clinical trials. Dr. Stark brings a unique vision to the industry and is a motivated designer of superior approaches to research challenges.

Xact Aid, Inc. CEO, Robert Pautsch, says, "We are very excited to bring Dr. Stark aboard the Company to help with the regulatory and research elements of our business. Dr. Stark will add great value to our mission of developing value added diagnostic testing devices that enhance people's lives."

About Xact Aid

Xact Aid, Inc. is a bio medical firm focusing on life science solutions for the sexually transmitted disease marketplace.

For more information please visit our website at www.xactaid.com or contact Ben Kirk at 1 (800) 605-1577.

Safe Harbor

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions.

Contact Information